ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)

Volume 12, 10 Issues, 2015

Download PDF Flyer

Current Alzheimer Research

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 34th of 192 in Clinical Neurology
  • 69th of 252 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Prof. Debomoy K. Lahiri
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.889
5 - Year: 3.933

Upcoming Articles (E-Pub Abstracts ahead of Print)

Prevalence of cognitive impairment and dementia in Malays – Epidemiology of Dementia in Singapore Study

S Hilal, CS Tan, S Xin, SM Amin, TY Wong, C Chen, N Venketasubramanian and MK Ikram.

View Abstract

Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome

E Hamlett, HA Boger, A Ledreux, CM Kelley, EJ Mufson, MF Falangola, DN Guilfoyle, RA Nixon, D Patterson, N Duval and AE Granholm.

View Abstract View on PubMed

Clinical Assessment of Cognitive Decline in Adults with Down Syndrome

M Sabbagh and J Edgin.

View Abstract View on PubMed

Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy

C Phillips, A Fahimi, D Das, FS Mojabi, R Ponnusamy and A Salehi.

View Abstract View on PubMed

The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s disease

MF Iulita and CA Claudio Cuello.

View Abstract View on PubMed

Maternal choline supplementation:A potential prenatal treatment for Down syndrome and Alzheimer’s disease

BJ Strupp, BE Powers, R Velazquez, JA Ash, CM Kelley, MJ Alldred, M Strawderman, MA Caudill, EJ Mufson and SD Ginsberg.

View Abstract View on PubMed

Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome

CM Kelley, JA Ash, BE Powers, R Velazquezc, MJ Alldred, MD Ikonomovic, SD Ginsberg, BJ Strupp and EJ Mufson.

View Abstract View on PubMed

Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in Alzheimer’s disease

S Serini and G Calviello.

View Abstract View on PubMed

Nitric Oxide Homeostasis in Neurodegenerative Diseases

L Hannibal.

View Abstract View on PubMed

The Pathophysiology of Heme in the Brain

R Gozzelino.

View Abstract View on PubMed

The role of brain cholesterol and its oxidized products in Alzheimer's disease

AM Giudetti, A Romano, AM Lavecchia and S Gaetani.

View Abstract View on PubMed

Amyloid-β in the Cerebrospinal Fluid of APP Transgenic Mice Does not Show Prion-like Properties

Skachokova Z, Sprenger F, Breu K, Abramowski D, Clavaguera F, Hench J, Staufenbiel M, Tolnay M and Winkler DT.

View Abstract

Cognitive improvement by photic stimulation in a mouse model of Alzheimer’s disease

Zhang Y, Wang F, Luo X, Wang L, Sun P, Wang M, Jiang Y, Yamamoto R, Sugai T, Yamamoto K and Kato N.

View Abstract

A co-module regulated by therapeutic drugs in a molecular subnetwork of Alzheimer’s disease identified on the basis of traditional Chinese medicine and SAMP8 mice

Cheng X-r, Cui X-L, Zheng Y, Zhang G-R, Li P, Huang H, Zhao Y-Y, Bo X-C, Wang S-Q, Zhou W-X and Zhang Y-X.

View Abstract

Functional connectivity hubs could serve as a potential biomarker in Alzheimer’s disease: a reproducible study

Sui X, Zhu M, Cui Y, Yu C, Sui J, Zhang X, Liu J, Duan Y, Zhang Z, Wang L, Zhang X and Jiang T.

View Abstract

Serum fragments of Tau for the differential diagnosis of Alzheimer's disease

Inekci D, Henriksen K, Linemann T, Karsdal MA, Habib A, Bisgaard C, Eriksen FB and Vilholm OJ.

View Abstract

Prevalence of Sinusitis Detected by Magnetic Resonance Imaging in Subjects with Dementia or Alzheimer’s Disease

Yasue M, Sugiura S, Uchida Y, Otake H, Teranishi M, Sakurai T, Toba K, Shimokata H, Ando F, Otsuka R and Nakashima T.

View Abstract

Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer’s Disease

L Frings, TS Spehl, M Hüll and PT Meyer.

View Abstract

The Role of α-Synuclein in Neurodegenerative Diseases: From Molecular Pathways in Disease to Therapeutic Approaches

Al- Mansoori KM, Hasan MY, Al- Hayani A and El- Agnaf OMA.

View Abstract

Bioavailability of 13-desmethyl spirolide C and improvement of Alzheimer disease markers in vivo observed by Proton magnetic resonance spectroscopy and immunoblotting analysis

E Alonso, P. Otero, C. Vale, A. Alfonso, A. Antelo, L. Giménez-Llort, L. Chabaud, C. Guillou and L M Botana.

View Abstract

Pro-inflammatory cytokines IL-1? and TNF-? are not associated with blood homocysteine concentration in Alzheimer's disease

L. Veryard, E. Jones, G. Weaving, E. Smith, L. Cheek, A. Wickramasinghe and N Tabet.

View Abstract

Natural Modulators of Amyloid-Beta Precursor Protein Processing

Zhang C and Tanzi RE.

View Abstract

Current advancements in Ab luminescent probes and inhibitors of Ab aggregation

C-H Leung, DS-H Chan, VP-Y Ma, K-H Leung and H-J Zhong.

View Abstract


Related Journals

Related eBooks

Webmaster Contact: Copyright © 2015 Bentham Science